CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
123 hedge funds and large institutions have $399M invested in Concert Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $423M → $399M (-$23.5M)
Holders
123
Holding in Top 10
1
Calls
$1.29M
Puts
$410K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$9.29M | |
| 3 | +$8.02M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.93M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$5.28M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$12.2M | |
| 3 | -$10.3M | |
| 4 |
Millennium Management
New York
|
-$6.73M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5.72M |